In this article we are going to explore the fascinating world of SL-164. From its impact on society to its implications in everyday life, SL-164 has become a topic of great interest in recent times. Throughout the next few lines, we will analyze different aspects related to SL-164, from its origin to its evolution today. Additionally, we will examine various opinions and perspectives on SL-164, with the aim of providing a comprehensive and enriching view on this topic. Without a doubt, SL-164 awakens endless emotions and reflections that are worth exploring in depth. Join us on this journey of discovery and learning about SL-164!
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H12Cl2N2O |
Molar mass | 319.19 g·mol−1 |
3D model (JSmol) | |
| |
|
SL-164, also known as dicloqualone or DCQ, is an analogue of methaqualone developed in the late 1960s by a team at Sumitomo. SL-164 has similar sedative, hypnotic and anticonvulsant properties to the parent compound, but was never marketed for clinical use.